Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis
Status:
Not yet recruiting
Trial end date:
2028-12-31
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate the efficacy of a therapeutic regimen which decreases
glucocorticoid exposure compared with standard therapy in patients with proliferative lupus
nephritis during remission induction by evaluating the histological and clinical remission.